- Home
- ONEG vs ANVS Comparison
ONEG vs ANVS Comparison
Compare ONEG & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEG
- ANVS
- Stock Information
- Founded
- ONEG 2021
- ANVS 2008
- Country
- ONEG Hong Kong
- ANVS United States
- Employees
- ONEG N/A
- ANVS N/A
- Industry
- ONEG Homebuilding
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- ONEG Consumer Discretionary
- ANVS Health Care
- Exchange
- ONEG Nasdaq
- ANVS Nasdaq
- Market Cap
- ONEG 27.3M
- ANVS 24.2M
- IPO Year
- ONEG 2024
- ANVS 2020
- Fundamental
- Price
- ONEG $3.30
- ANVS $1.53
- Analyst Decision
- ONEG
- ANVS Strong Buy
- Analyst Count
- ONEG 0
- ANVS 4
- Target Price
- ONEG N/A
- ANVS $40.67
- AVG Volume (30 Days)
- ONEG 46.8K
- ANVS 461.4K
- Earning Date
- ONEG 01-01-0001
- ANVS 05-20-2025
- Dividend Yield
- ONEG N/A
- ANVS N/A
- EPS Growth
- ONEG N/A
- ANVS N/A
- EPS
- ONEG 0.12
- ANVS N/A
- Revenue
- ONEG $60,903,000.00
- ANVS N/A
- Revenue This Year
- ONEG N/A
- ANVS N/A
- Revenue Next Year
- ONEG N/A
- ANVS N/A
- P/E Ratio
- ONEG $26.44
- ANVS N/A
- Revenue Growth
- ONEG 16.46
- ANVS N/A
- 52 Week Low
- ONEG $1.48
- ANVS $1.11
- 52 Week High
- ONEG $4.05
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- ONEG N/A
- ANVS 49.17
- Support Level
- ONEG N/A
- ANVS $1.42
- Resistance Level
- ONEG N/A
- ANVS $1.75
- Average True Range (ATR)
- ONEG 0.00
- ANVS 0.16
- MACD
- ONEG 0.00
- ANVS 0.03
- Stochastic Oscillator
- ONEG 0.00
- ANVS 43.59
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. It is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.